Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
5.64
-0.58 (-9.32%)
At close: Nov 15, 2024, 4:00 PM
5.72
+0.08 (1.42%)
After-hours: Nov 15, 2024, 4:08 PM EST
Voyager Therapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$17.00
Upside
+201.42%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +148.23% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +431.91% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +431.91% | Oct 24, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $15 | Buy | Initiates | $15 | +165.96% | Oct 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +431.91% | Aug 20, 2024 |
| Wedbush | Wedbush | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +24.11% | Aug 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +431.91% | Jul 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +431.91% | May 16, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $18 | Buy | Maintains | $18 | +219.15% | May 15, 2024 |
| Wedbush | Wedbush | Hold Maintains $10 → $8 | Hold | Maintains | $10 → $8 | +41.84% | May 14, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +290.07% | Mar 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +431.91% | Mar 19, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +183.69% | Mar 7, 2024 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $9 → $14 | Hold → Buy | Upgrades | $9 → $14 | +148.23% | Jan 2, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $16 | Buy | Reiterates | $16 | +183.69% | Aug 7, 2023 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $10 → $14 | Strong Buy | Maintains | $10 → $14 | +148.23% | May 10, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.